Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,323 | 41,125 | 53,961 | 62,503 | 70,390 |
| Receivables | 227 | 227 | 100 | 158 | N/A |
| Other current assets | 482 | 477 | 468 | 459 | 1,833 |
| TOTAL | $31,679 | $42,836 | $55,457 | $63,682 | $72,989 |
| Non-Current Assets | |||||
| PPE Net | N/A | 17 | 65 | 112 | 153 |
| Other Non-Current Assets | 3,534 | 3,672 | 3,809 | 3,948 | 2,590 |
| TOTAL | $3,534 | $3,689 | $3,874 | $4,060 | $2,743 |
| Total Assets | $35,213 | $46,525 | $59,331 | $67,742 | $75,732 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,767 | 2,519 | 1,828 | 1,174 | 1,386 |
| Accrued Expenses | 7,085 | 6,972 | 9,257 | 6,672 | 5,615 |
| TOTAL | $9,852 | $9,491 | $11,085 | $11,355 | $10,510 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,852 | $9,491 | $11,085 | $11,355 | $10,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,174 | 2,172 | 2,171 | 2,166 | 2,164 |
| Retained earnings | -241,442 | -228,054 | -215,076 | -204,300 | -193,010 |
| Other shareholders' equity | -25 | -24 | -23 | -26 | -26 |
| TOTAL | $25,361 | $37,034 | $48,246 | $56,387 | $65,222 |
| Total Liabilities And Equity | $35,213 | $46,525 | $59,331 | $67,742 | $75,732 |